Literature DB >> 12163017

Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy.

P Anthony Akkari1, Yuhua Song, Sarah Hitchcock-DeGregori, Lori Blechynden, Nigel Laing.   

Abstract

We have previously reported a Met9Arg mutation in the human skeletal muscle alpha tropomyosin gene (TPM3) associated with autosomal dominant nemaline myopathy [Nat. Genet. 9 (1995) 75]. We describe here the generation of wild-type (Wt-tpm3) and Met9Arg (M9R-tpm3) mutant human skeletal muscle slow alpha tropomyosin using the Baculovirus expression vector system (BEVS). This system produces correct posttranslationally modified recombinant tropomyosin proteins in insect cells. We show that the interactions of Wt-tpm3 with actin and tropomyosin are comparable to those of fast alpha tropomyosin isolated from chicken striated muscle. However, the recombinant M9R-tpm3 is at least 100 times less effective at binding actin than Wt-tpm3. This paper represents the first study of this mutation directly on the human isoform of tropomyosin that is involved in nemaline myopathy. It also represents the first time that human tpm3 has been produced using BEVS. This system can now be used to accurately demonstrate the effect of this (and other disease-associated tropomyosin mutations) on the interactions of tpm3 with the other protein components of the muscle thin filament, including those responsible for differing forms of nemaline myopathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163017     DOI: 10.1016/s0006-291x(02)00852-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Functional outcomes of structural peculiarities of striated muscle tropomyosin.

Authors:  Galina V Kopylova; Alexander M Matyushenko; Natalia A Koubassova; Daniil V Shchepkin; Sergey Y Bershitsky; Dmitrii I Levitsky; Andrey K Tsaturyan
Journal:  J Muscle Res Cell Motil       Date:  2019-09-18       Impact factor: 2.698

2.  Functional effects of mutations in the tropomyosin-binding sites of tropomodulin1 and tropomodulin3.

Authors:  Raymond A Lewis; Sawako Yamashiro; David S Gokhin; Velia M Fowler
Journal:  Cytoskeleton (Hoboken)       Date:  2014-07-02

3.  Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology.

Authors:  David S Gokhin; Raymond A Lewis; Caroline R McKeown; Roberta B Nowak; Nancy E Kim; Ryan S Littlefield; Richard L Lieber; Velia M Fowler
Journal:  J Cell Biol       Date:  2010-04-05       Impact factor: 10.539

Review 4.  Dynamic regulation of sarcomeric actin filaments in striated muscle.

Authors:  Shoichiro Ono
Journal:  Cytoskeleton (Hoboken)       Date:  2010-11

5.  Disease severity and thin filament regulation in M9R TPM3 nemaline myopathy.

Authors:  Biljana Ilkovski; Nancy Mokbel; Raymond A Lewis; Kendall Walker; Kristen J Nowak; Ana Domazetovska; Nigel G Laing; Velia M Fowler; Kathryn N North; Sandra T Cooper
Journal:  J Neuropathol Exp Neurol       Date:  2008-09       Impact factor: 3.685

6.  Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate.

Authors:  Maria Papadaki; Petr G Vikhorev; Steven B Marston; Andrew E Messer
Journal:  Cardiovasc Res       Date:  2015-06-24       Impact factor: 10.787

7.  Mutations in repeating structural motifs of tropomyosin cause gain of function in skeletal muscle myopathy patients.

Authors:  Steven Marston; Massimiliano Memo; Andrew Messer; Maria Papadaki; Kristen Nowak; Elyshia McNamara; Royston Ong; Mohammed El-Mezgueldi; Xiaochuan Li; William Lehman
Journal:  Hum Mol Genet       Date:  2013-07-25       Impact factor: 6.150

8.  Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres.

Authors:  Michaela Yuen; Sandra T Cooper; Steve B Marston; Kristen J Nowak; Elyshia McNamara; Nancy Mokbel; Biljana Ilkovski; Gianina Ravenscroft; John Rendu; Josine M de Winter; Lars Klinge; Alan H Beggs; Kathryn N North; Coen A C Ottenheijm; Nigel F Clarke
Journal:  Hum Mol Genet       Date:  2015-08-24       Impact factor: 6.150

9.  TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype.

Authors:  M Papadaki; J M de Winter; M B Neu; S Donkervoort; J Kirschner; V Bolduc; M L Yang; M A Gibbons; Y Hu; J Dastgir; M E Leach; A Rutkowski; A R Foley; M Krüger; E P Wartchow; E McNamara; R Ong; K J Nowak; N G Laing; N F Clarke; Cac Ottenheijm; S B Marston; C G Bönnemann
Journal:  Ann Neurol       Date:  2015-11-13       Impact factor: 10.422

10.  Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.

Authors:  Minttu Marttila; Vilma-Lotta Lehtokari; Steven Marston; Tuula A Nyman; Christine Barnerias; Alan H Beggs; Enrico Bertini; Ozge Ceyhan-Birsoy; Pascal Cintas; Marion Gerard; Brigitte Gilbert-Dussardier; Jacob S Hogue; Cheryl Longman; Bruno Eymard; Moshe Frydman; Peter B Kang; Lars Klinge; Hanna Kolski; Hans Lochmüller; Laurent Magy; Véronique Manel; Michèle Mayer; Eugenio Mercuri; Kathryn N North; Sylviane Peudenier-Robert; Helena Pihko; Frank J Probst; Ricardo Reisin; Willie Stewart; Ana Lia Taratuto; Marianne de Visser; Ekkehard Wilichowski; John Winer; Kristen Nowak; Nigel G Laing; Tom L Winder; Nicole Monnier; Nigel F Clarke; Katarina Pelin; Mikaela Grönholm; Carina Wallgren-Pettersson
Journal:  Hum Mutat       Date:  2014-05-01       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.